200,000+ products from a single source!
sales@angenechem.com
137275-80-0 | 1,4-Benzodioxin-2-methanamine, N-[3-(1,3-benzodioxol-5-yloxy)propyl]-2,3-dihydro-, hydrochloride (1:1), (2S)-
CAS No: 137275-80-0 Catalog No: AG00131Y MDL No:
Product Description
Catalog Number:
AG00131Y
Chemical Name:
1,4-Benzodioxin-2-methanamine, N-[3-(1,3-benzodioxol-5-yloxy)propyl]-2,3-dihydro-, hydrochloride (1:1), (2S)-
CAS Number:
137275-80-0
Molecular Formula:
C19H22ClNO5
Molecular Weight:
379.8347
IUPAC Name:
3-(1,3-benzodioxol-5-yloxy)-N-[[(3S)-2,3-dihydro-1,4-benzodioxin-3-yl]methyl]propan-1-amine;hydrochloride
InChI:
InChI=1S/C19H21NO5.ClH/c1-2-5-18-16(4-1)22-12-15(25-18)11-20-8-3-9-21-14-6-7-17-19(10-14)24-13-23-17;/h1-2,4-7,10,15,20H,3,8-9,11-13H2;1H/t15-;/m0./s1
InChI Key:
GGNCUSDIUUCNKE-RSAXXLAASA-N
SMILES:
C(NC[C@H]1COc2c(O1)cccc2)CCOc1ccc2c(c1)OCO2.Cl
UNII:
F0WKFYPQL8
Properties
Complexity:
409
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2
Defined Atom Stereocenter Count:
1
Defined Bond Stereocenter Count:
0
Exact Mass:
379.119g/mol
Formal Charge:
0
Heavy Atom Count:
26
Hydrogen Bond Acceptor Count:
6
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
379.837g/mol
Monoisotopic Mass:
379.119g/mol
Rotatable Bond Count:
7
Topological Polar Surface Area:
58.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
| Title | Journal |
|---|---|
| Inhibitory effects of osemozotan, a serotonin 1A-receptor agonist, on methamphetamine-induced c-Fos expression in prefrontal cortical neurons. | Biological & pharmaceutical bulletin 20090401 |
| An antihyperkinetic action by the serotonin 1A-receptor agonist osemozotan co-administered with psychostimulants or the non-stimulant atomoxetine in mice. | Journal of pharmacological sciences 20090301 |
| Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice. | Journal of pharmacological sciences 20080101 |
| Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice. | Neuropharmacology 20060901 |
| Effects of osemozotan, ritanserin and azasetron on cocaine-induced behavioral sensitization in mice. | Pharmacology, biochemistry, and behavior 20060901 |
| Inhibitory action of 5-HT1A agonist MKC-242 on triazolam-induced phase advances in hamster circadian activity rhythms. | Journal of pharmacological sciences 20050501 |
| The 5-HT1A receptor agonist MKC-242 reverses isolation rearing-induced deficits of prepulse inhibition in mice. | Psychopharmacology 20031001 |
| The 5-HT1A receptor agonist MKC-242 increases the exploratory activity of mice in the elevated plus-maze. | European journal of pharmacology 20030101 |
| Selective reduction by isolation rearing of 5-HT1A receptor-mediated dopamine release in vivo in the frontal cortex of mice. | Journal of neurochemistry 20021001 |
| Extended action of MKC-242, a selective 5-HT(1A) receptor agonist, on light-induced Per gene expression in the suprachiasmatic nucleus in mice. | Journal of neuroscience research 20020515 |
| Modulation by 5-hT2A receptors of aggressive behavior in isolated mice. | Japanese journal of pharmacology 20020501 |
| Palladium-catalyzed intramolecular C-O bond formation. | Journal of the American Chemical Society 20011212 |
| Involvement of benzodiazepine binding sites in an antiaggressive effect by 5-HT(1A) receptor activation in isolated mice. | European journal of pharmacology 20011207 |
| Functional alteration of brain dopaminergic system in isolated aggressive mice. | Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20010901 |
| [Behavioral and neurochemical study on the mechanism of the anxiolytic effect of a selective serotonin reuptake inhibitor, a selective serotonin1A agonist and lithium carbonate]. | [Hokkaido igaku zasshi] The Hokkaido journal of medical science 20010301 |
| Effect of subchronic lithium treatment on citalopram-induced increases in extracellular concentrations of serotonin in the medial prefrontal cortex. | Journal of neurochemistry 20010101 |
| Clinical trials of propentofylline in vascular dementia. European/Canadian Propentofylline Study Group. | Alzheimer disease and associated disorders 19990101 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.